Jane Street’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.78M | Sell |
113,900
-43,400
| -28% | -$1.29M | ﹤0.01% | 3957 |
|
|
2025
Q4 | $4.69M | Sell |
157,300
-99,000
| -39% | -$3.23M | ﹤0.01% | 3335 |
|
|
2025
Q3 | $9.26M | Buy |
256,300
+7,100
| +3% | +$234K | ﹤0.01% | 2517 |
|
|
2025
Q2 | $8.97M | Sell |
249,200
-69,600
| -22% | -$2.59M | ﹤0.01% | 2269 |
|
|
2025
Q1 | $12.6M | Sell |
318,800
-120,400
| -27% | -$4.05M | ﹤0.01% | 1725 |
|
|
2024
Q4 | $13.2M | Buy |
439,200
+125,600
| +40% | +$3.6M | ﹤0.01% | 1641 |
|
|
2024
Q3 | $7.34M | Buy |
313,600
+135,100
| +76% | +$2.95M | ﹤0.01% | 2295 |
|
|
2024
Q2 | $3.18M | Sell |
178,500
-37,600
| -17% | -$600K | ﹤0.01% | 3725 |
|
|
2024
Q1 | $3.29M | Sell |
216,100
-274,500
| -56% | -$4.37M | ﹤0.01% | 3254 |
|
|
2023
Q4 | $8.38M | Buy |
490,600
+243,800
| +99% | +$2.83M | ﹤0.01% | 2173 |
|
|
2023
Q3 | $2.06M | Sell |
246,800
-445,000
| -64% | -$6.2M | ﹤0.01% | 4010 |
|
|
2023
Q2 | $17.2M | Buy |
691,800
+445,100
| +180% | +$11.5M | 0.01% | 1355 |
|
|
2023
Q1 | $3.71M | Sell |
246,700
-199,100
| -45% | -$3.02M | ﹤0.01% | 2849 |
|
|
2022
Q4 | $5.27M | Sell |
445,800
-324,000
| -42% | -$2.35M | ﹤0.01% | 2400 |
|
|
2022
Q3 | $4.56M | Buy |
769,800
+380,800
| +98% | +$2.5M | ﹤0.01% | 2766 |
|
|
2022
Q2 | $1.65M | Buy |
389,000
+83,900
| +27% | +$524K | ﹤0.01% | 4519 |
|
|
2022
Q1 | $2.9M | Buy |
305,100
+118,500
| +64% | +$1.37M | ﹤0.01% | 4022 |
|
|
2021
Q4 | $3.54M | Buy |
186,600
+54,400
| +41% | +$1.41M | ﹤0.01% | 3407 |
|
|
2021
Q3 | $4.4M | Buy |
132,200
+52,800
| +66% | +$1.63M | ﹤0.01% | 2947 |
|
|
2021
Q2 | $3.08M | Sell |
79,400
-65,000
| -45% | -$2.55M | ﹤0.01% | 3530 |
|
|
2021
Q1 | $6.96M | Sell |
144,400
-183,400
| -56% | -$8.81M | ﹤0.01% | 1959 |
|
|
2020
Q4 | $17.1M | Buy |
327,800
+105,300
| +47% | +$3.56M | 0.01% | 978 |
|
|
2020
Q3 | $5.95M | Sell |
222,500
-123,900
| -36% | -$2.85M | ﹤0.01% | 1675 |
|
|
2020
Q2 | $6.75M | Buy |
346,400
+275,000
| +385% | +$4.43M | 0.01% | 1516 |
|
|
2020
Q1 | $703K | Buy |
71,400
+50,500
| +242% | +$638K | ﹤0.01% | 3246 |
|
|
2019
Q4 | $232K | Buy |
+20,900
| New | +$159K | ﹤0.01% | 4572 |
|
|
2019
Q3 | – | Sell |
-16,100
| Closed | -$139K | – | 5742 |
|
|
2019
Q2 | $139K | Sell |
16,100
-7,600
| -32% | -$57.5K | ﹤0.01% | 4781 |
|
|
2019
Q1 | $191K | Buy |
+23,700
| New | +$128K | ﹤0.01% | 4668 |
|
|
2018
Q4 | – | Sell |
-27,500
| Closed | -$154K | – | 5704 |
|
|
2018
Q3 | $154K | Sell |
27,500
-32,900
| -54% | -$376K | ﹤0.01% | 4768 |
|
|
2018
Q2 | $794K | Buy |
60,400
+20,000
| +50% | +$275K | ﹤0.01% | 3034 |
|
|
2018
Q1 | $574K | Buy |
+40,400
| New | +$516K | ﹤0.01% | 3328 |
|
Other funds holding TGTX
VPM
VCM
SCM
CAM
Jane Street's TGTX Position: Q1 2026 in Review
Jane Street increased its TG Therapeutics (TGTX) stake by 110% in Q1 2026, buying an estimated $31.9M and bringing the position to 2,041,669 shares worth $67.8M. The position accounts for 0.01% of the portfolio, ranked #863.
Jane Street first reported a position in TGTX in Q2 2013 and has held it in 32 quarters since. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.
- Jane Street held 2,041,669 shares of TG Therapeutics worth $67.8M as of Q1 2026.
- Jane Street bought 1,071,694 TG Therapeutics shares in Q1 2026, an estimated $31.9M.
- TG Therapeutics made up 0.01% of Jane Street's portfolio in Q1 2026, its #863 holding.
- Jane Street first reported a position in TG Therapeutics in Q2 2013 and has held it in 32 quarters since.
- 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.